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Abstract
In this paper, we discussed an infinitely distributed delayed viral infection model with nonlinear
immune response and general incidence rate. We proved the existence and uniqueness of the
equilibria. By using the Lyapunov functional and LaSalle invariance principle, we obtained the
conditions of global stabilities of the infection-free equilibrium, the immune-exhausted equilibrium
and the endemic equilibrium. Numerical simulations are given to verify the analytical results.
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1. Introduction
During recent decades there has been a lot of research regarding mathematical modelling of
viruses dynamics via models of ordinary differential equations (ODE). Advances in immunology
have lead us to better understand the interactions between populations of virus and the immune
system, therefore several nonlinear sytems of ordinary differential equations (ODE’s) has been
proposed. Nowak and Bengham [1] study the model
x′(t) = s− dx(t)− βx(t)v(t), (1)
y′(t) = βx(t)v(t)− ay(t)− py(t)z(t), (2)
v′(t) = ky(t)− uv(t), (3)
z′(t) = cy(t)z(t)− bz(t). (4)
Where x(t) denotes the number of healthy cells, y(t) denotes the infected cells, v(t) denotes the
number of matures viruses and z(t) denotes the number of CTL (cytotoxic T lymphocyte response)
cells. Uninfected target cells are assumed to be generated at a constant rate s and die at rate d.
Infection of target cells by free virus is assumed to occur at rate β. Infected cells die at rate a
and are removed at rate p by the CTL immune response. New virus is produced from infected
cells at rate k and dies at rate u. The average lifetime of uninfected cells, infected cells and free
virus is thus given by 1/d, 1/a and 1/u, respectively. c denotes rate at which the CTL response
is produced, and b denotes death rate of the CTL response, respectively, with all given constants
positive.
∗Corresponding author: avila@correo.uady.mx
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Generally, the type of incidence function used in a model has an important role in modeling
the dynamics of viruses. The most common, is the bilinear incidence rate βxv. However, this
rate is not useful all the time. For instance, using bilinear incidence suggests that model can not
describe the infection process of hepatitis B, where individuals with small liver are more resistant
to infection than the ones with a bigger liver. Recently, works about models of infections by
viruses have used the incidence function of type Beddington-DeAngelis and Crowley-Martin. In
[2] the authors propose a model of infection by virus with Crowley-Martin functional response
βx(t)v(t)
(1+ax(t))(1+bv(t))
. Li and Fu in [3] study the following system:
x′(t) = s− dx(t)−
βx(t)v(t)
(1 + ax(t))(1 + bv(t))
, (5)
y′(t) =
βx(t− τ)v(t)e−sτ
(1 + ax(t− τ))(1 + bv(t− τ))
− ay(t)− py(t)z(t), (6)
v′(t) = ky(t)− uv(t), (7)
z′(t) = cy(t)z(t)− bz(t). (8)
They construct a Lyapunov functional to establish the global dynamics of the system.
More recently, in [4], the authors consider the system
x′(t) = s− dx(t)−
βx(t)v(t)
1 + ax(t) + bv(t)
, (9)
y′(t) =
βx(t)v(t)
1 + ax(t) + bv(t)
− ay(t)− py(t)z(t), (10)
v′(t) = ky(t)− uv(t), (11)
z′(t) = cy(t− τ)z(t − τ)− bz(t). (12)
They give also results of global stability as well as Hopf bifurcation results.
Yang and Wei in [5] consider a more general incidence rate, they study the system
x′(t) = s− dx(t)− x(t)f(v(t)), (13)
y′(t) = x(t)f(v(t))− ay(t)− py(t)z(t), (14)
v′(t) = ky(t)− uv(t), (15)
z′(t) = cy(t)z(t)− bz(t), (16)
giving some results about global stability in terms of the basic reproduction number and the
immune response reproduction number. Here the f(v) is assumed to be a continuous function on v
that belongs to (0,∞) and satisfies f(0) = 0, f ′(v) > 0 for all v greater or equal to 0 and f ′′(v) < 0
for all v greater or equal to 0.
In [6] the authors consider a more general incidence rate f(x, y, v)v, where f is assumed to be
continuously differentiable in the interior of R3+ and satisfies the following hypotheses
i) f(0, y, v) = 0, for all y ≥ 0, v ≥ 0.
ii) ∂f
∂x
(x, y, v) > 0 for all x > 0, y > 0, v > 0.
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iii) ∂f
∂y
(x, y, v) ≤ 0 and ∂f
∂v
(x, y, v) ≤ 0 for all x ≥ 0, y ≥ 0, v ≥ 0.
Finally, in [7] analyse an infection model by virus , with general incidence and immune response,
which generalizes the systems by [2, 6, 8]:
x˙ = s− dx− f(x, y, v)v,
y˙ = f(x, y, v)v − ay − pyz,
v˙ = ky − uv,
z˙ = cyz − bz,
where f(x, y, v) is a continuous and differentiable function in the interior of R3+ and satisfies
the conditions [i)], [ii) [iii)].
Another viral infection model is the studied in [9] given by:
x˙ = n(x)− h(x, v),
y˙ =
∫ ∞
0
f1(τ)h(x(t− τ), v(t− τ))dτ − ag1(y)− pw(y, z),
v˙ = k
∫ ∞
0
f2(τ)g1(y(t− τ))dτ,
z˙ = c
∫ ∞
0
f3(τ)w(y(t− τ), z(t − τ))dτ − bg3(z).
Where x, y, v, z denotes the non infected cells, infected cells, virus and specific virus CTL at
time t, respectively. Conditions on functions fi,h, w, and gi are specified in [9]. A related work is
[10].
Based on the discussion above, we will study a delayed viral infection model with general
incidence rate and CTL immune response given by
x˙ = n(x)− f(x(t), y(t), v(t))v(t), (17)
y˙ =
∫ ∞
0
f1(τ)f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)e
−α1τdτ − aϕ1(y(t))− pw(y(t), z(t)), (18)
v˙ = k
∫ ∞
0
f2(τ)e
−α2τϕ1(y(t− τ))dτ − uv(t), (19)
z˙ = c
∫ ∞
0
f3(τ)w(y(t− τ), z(t − τ))dτ − bϕ2(z(t)). (20)
The dynamics of uninfected cells, x, in absence of infection is governed by x′ = n(x), where
n(x) is the intrinsic growth rate of uninfected cells accounting for both productions and natural
mortality, which is assumed to satisfy the following:
H1) n(x) is continuously differentiable, and exist x¯ > 0 such as that n(x¯) = 0, n(x) > 0 for
x ∈ [0, x¯), and n(x) < 0 for x < x¯. Typical functions appearing in the literature are
n(x) = s− dx and n(x) = s− dx+ rx (1− x/xmax).
H2) ϕi is strictly increasing on [0,∞); ϕi(0) = 0; ϕ
′
i(0) = 1;limy−→∞ ϕi(y) = +∞; and exist
ki > 0 such as ϕi(y) ≥ kiy for any yi ≥ 0.
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H3) w(y, z) is continuously differentiable;
∂w(y,z)
∂z
> 0 for y ∈ (0,∞), z ∈ [0,∞); w(y, z) > 0 for
y ∈ (0,∞) and z ∈ (0,∞) with w(y, z) = 0 if and if only y = 0 or z = 0.
All parameters are nonnegative and the distributions fi for i = 1, 2 are assumed to satisfy the
following (see [9] and [11] ) :
• fi(τ) ≥ 0, for τ ≥ 0.
•
∫∞
0
fi(τ)dτ = 1 for i = 1, 2.
•
∫∞
0
f3(τ)dτ ≤ 1 and
∫∞
0
f3(τ)e
sτdτ <∞ for some s > 0.
However, the uniqueness and Global stability results on the positive equilibrium require the
following assumption.
H4) w(y, z) = ϕ1(y)ϕ2(z).
Motivated by the work mentioned above we consider the following model
x˙ = n(x)− f(x(t), y(t), v(t))v(t), (21)
y˙ =
∫ ∞
0
f1(τ)f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)e
−α1τdτ − aϕ1(y(t))− pϕ1(y(t))ϕ2(z(t)),
(22)
v˙ = k
∫ ∞
0
f2(τ)e
−α2τϕ1(y(t− τ))dτ − uv(t), (23)
z˙ = c
∫ ∞
0
f3(τ)ϕ1(y(t− τ))ϕ2(z(t− τ))dτ − bϕ2(z(t)). (24)
In this paper, we will study the global dynamics model of (21), organization is as follows:
in section 2, we prove the existence and uniqueness of the infection free equilibrium, the CTL-
inactivated infection equilibrium and the CTL-activated infection equilibrium. In section 3, the
conditions that allow the global stability of each equilibrium are determined and proved. Section 4
provide several numerical simulations that shows the results obtained in section 3 and 4. Finally,
in section 5 we summarize the results obtained, comparing them with the previous models studied
in literature, and setting the guidelines for possible future work.
1.1. Positivity and Boundedness
For system (21) the suitable space is C4 = C ×C ×C ×C, where C is the Banach space of fading
memory type ([12]):
C := {φ ∈ C((−∞, 0],R), φ(θ)eαθ is uniformly continous for θ ∈ (−∞, 0] and ‖φ‖ <∞},
where α > 0 is a constant and the norm of a φ ∈ C is defined as ‖φ‖ = supθ≤0 |φ(θ)|e
αθ. The
nonnegative cone of C is defined as C+ = C((−∞, 0],R+).
Theorem 1. Under the initial conditions, all solutions of system (21) are positive and ultimately
uniformly bounded in X.
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Proof. To see that x(t) is positive, we proceed by contradiction. Let t1 the first value of time such
that x(t1) = 0. From the first equation of (21) we see that x
′(t1) = n(0) > 0 and x(t1) = 0,
therefore there exists ǫ > 0 such that x(t) < 0 for t ∈ (t1 − ǫ, t1), this leads to a contradiction. It
follows that x(t) is always positive. With a similar argument we see that y(t), v(t) and z(t) are
positive for t ≥ 0.
The hypotheses (H1) and first equation of (21) imply that lim supt−→∞ x(t) ≤ x¯.
From two first equations of (21) and assumption (H2), we obtain
∫ ∞
0
f1(τ)e
−α1τx′(t− τ)dτ + y′(t) =
∫ ∞
0
f1(τ)e
−α1τn(x(t− τ))dτ − aϕ1(y) ≤M1G1 − ak1y, (25)
where M1 = supx∈[0,x¯] n(x) and G1 =
∫∞
0
f1(τ)e
−α1τdτ .
Let e(t) =
∫∞
0
f1(τ)e
−α1τx(t− τ)dτ . Then for e(t) ≤ x¯G1 for t > 0. Then
(e(t) + y(t))′ ≤M1G1 − ak1y
=M1G1 +M1G1 −M1G1 − ak1y
≤ 2M1G1 −
M1
x¯
e(t)− ak1y
≤ 2M1G1 − µ¯(e(t) + y(t)) where µ¯ = min
{
M1
x¯
, ak1
}
,
and thus lim supt−→∞(e(t) + y(t)) ≤
2M1G1
µ¯
. Since e(t) ≥ 0, we know that lim supt−→∞ y(t) ≤
2M1G1
µ¯
. From third equation of (21):
v˙ = k
∫ ∞
0
f2(τ)e
−α2τϕ1(y(t− τ))dτ − uv(t)
≤ kM2G2 − uv(t),
where M2 = supy∈[0, 2M1G1µ¯ ]
ϕ1(y) and G2 =
∫∞
0
f2(τ)e
−α2τdτ , and thus lim supt−→∞ v(t) ≤
kM2G2
u
.
Using an argument similar, let G3 =
∫∞
0
f3(τ)dτ , L(t) =
cG3
p
y(t) + z(t), µ˜ = min{ak1, bk2}
and M3 = sup(x,y,v)∈[0,x¯]×[0, 2M1G1
µ¯
]×[0,
kM2G2
u
]
f(x, y, v)v, then
L′(t) =
cG3
p
G1f(x, y, v)v −
acG3
p
ϕ1(y)− cG3ϕ1(y)ϕ2(z) + cG3ϕ1(y)ϕ2(z)− bϕ2(z)
≤
cG3G1
p
M3 −
acG3
p
k1y − bk2z
≤
cG3G1
p
M3 − µ˜
(
cG3
p
y + z
)
=
cG3G1
p
M3 − µ˜L(t),
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therefore lim supt−→∞ L(t) ≤
cG1G3M3
pµ˜
. Since cG3
p
y(t) ≥ 0, we know that lim supt−→∞ z(t) ≤
cG1G3M3
pµ˜
.
Therefore, x(t), y(t), v(t) and z(t) are ultimately uniformly bounded in C × C × C × C.
Theorem (1) implies that omega limit set of system (21) are contained in the following bounded
feasible region:
Γ =
{
(x, y, v, z) ∈ C4+ :‖ x ‖≤ x¯, ‖ y ‖≤
2M1G1
µ¯
, ‖ v ‖≤
kM2G2
u
, ‖ z ‖≤
cG1G3M3
pµ˜
}
.
It can be verified that the region Γ is positively invariant with respect to model (21) and that
the model is well posed.
2. Existence and uniqueness of equilibria of system
At any equilibrium we have
n(x)− f(x, y, v)v = 0, (26)
f(x, y, v)v −
a
G1
ϕ1(y)−
p
G1
ϕ1(y)ϕ2(z) = 0, (27)
kϕ1(y)−
u
G2
v = 0, (28)
cϕ1(y)ϕ2(z)−
b
G3
ϕ2(z) = 0. (29)
The system (21) always has an infection free equilibrium E0 = (x¯, 0, 0, 0). In addition to
E0 the system could have two types of Chronic infection Equilibria E1 = (x1, y1, v1, 0) and E2 =
(x2, y2, v2, z2) in Γ where the entries of E1 and E2 are strictly positives. The equilibria E1 and E2 are
called CTL-inactivated infection equilibrium (CTL-IE) and CTL-activated infection equilibrium
(CTL-AE), respectively.
We define the general reproduction number as
R(x, y, v) =
kG1G2f(x, y, v)
au
,
which is the ratio of the per capita production and decay rates of mature viruses at an equilib-
rium (x, y, v, z) with z = 0. In particular, at the infection free equilibrium, E0, we denote R(x¯, 0, 0)
by R0, representing the basic production number for viral infection:
R0 = R(x¯, 0, 0) =
kG1G2f(x¯, 0, 0)
au
. (30)
From assumption (H2) we have that ϕ1 is invertible, so we can define from equation (29):
yˆ = ϕ−11
(
b
cG3
)
, vˆ =
kϕ1(yˆ)G2
u
.
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Define also H(x) = n(x)−f(x, yˆ, vˆ)vˆ, we have H(0) = n(0) > 0 and H(x¯) = −f(x¯, yˆ, vˆ)vˆ, with
f(x¯, yˆ, vˆ) > f(0, yˆ, vˆ) = 0 by (ii), so there exists a xˆ ∈ (0, x¯) such that H(xˆ) = 0. We denote:
R1 = R(xˆ, yˆ, vˆ), (31)
and refer it as the viral reproduction number. From assumptions on f it is easy to see that
f(x¯, 0, 0) > f(x¯, y, v), for all y, v > 0, moreover for all x ∈ [0, x¯) we have f(x, y, v) < f(x¯, y, v), so:
R0 = R(x¯, 0, 0) > R(x¯, y, v) > R(x, y, v), ∀x ∈ [0, x¯), y, v > 0. (32)
Particularly, R0 > R1. The basic reproduction number for the CTL response is given by:
RCTL =
cG3ϕ1(y1)
b
.
For proof of the existence and uniqueness of equilibria, we require two additional assumption.
First, we define the following sets:
Xn = {ξ ∈ [0, x¯] : (n(x)− n(ξ))(x− ξ) < 0 for x 6= ξ, x ∈ [0, x¯]},
Xf(y, v) = {ξ ∈ [0, x¯] : (f(x, y, v)− f(ξ, y, v))(x− ξ) < 0 for x 6= ξ, x ∈ [0, x¯]},
X = ∩y,v∈(0,y¯)×(0,v¯)Xf (y, v) ∩Xn.
The following conditions are used to guarantee the uniqueness of the equilibria.
(A1) The system (21) has a E1 = (x1, y1, v1, 0) satisfying x1 ∈ X .
(A2) The system (21) has a E2 = (x2, y2, v2, z2) satisfying Xn ∩Xf (y2, v2).
Theorem 2. Assume that i)− iii) and H1 −H4 are satisfied.
1. If R0 ≤ 1, then E0 = (x0, 0, 0) is the unique equilibrium of the system(21).
2. if R1 ≤ 1 < R0 then in addition to E0, system (21) has a CTL inactivated infection equilib-
rium E1.
3. If R0 > R1 > 1 then, in addition to E0 and E1 system (21) has a CTL activated infection
equilibrium.
When x = x¯ and y = v = z = 0 the equations (26)-(29)are satisfied, therefore E0 = (x0, 0, 0, 0)
is a steady state called the infection free equilibrium. To proof that it is unique when R0 < 1, we
look for the existence of a positive equilibrium.
To find a positive equilibrium we proceed as follows: from equation (29) ϕ2(z) = 0 or ϕ1(y) =
b
cG1
. If ϕ2(z) = 0 then from assumption (H2) we get, z = 0 and using (26)-(28)
n(x) = f(x, y, v)v =
aϕ1(y)
G1
=
auv
kG1G2
. (33)
By (H2), we know that ϕ
−1
1 exists. Solving n(x) =
aϕ1(y)
G1
for y gives us that
y(x) = φ(x) = ϕ−11
(
n(x)G1
a
)
,
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with φ(x¯) = 0 and φ(0) = y0 is a unique root of equations n(0) = aϕ1(y
0)
G1
. Solving (28) for v we
obtain:
v(x) =
kn(x)G1G2
au
.
Note that, from (ii) we have f(x, y, v) > f(0, y, v) = 0, ∀x > 0. So if E∗ = (x∗, y∗, v∗, z∗) is a
positive equilibrium, then n(x∗) = f(x∗, y∗, v∗)v∗ > 0, so x∗ ∈ (0, x¯).
Now, using (33) define on the interval [0, x¯) the function G,
G(x) = f(x, y(x), v(x))−
n(x)
v(x)
,
= f
(
x, φ(x),
n(x)kG1G2
au
)
−
au
kG1G2
,
we have G(0) = − au
kG1G2
< 0, G(x¯) = f(x¯, 0, 0)− au
kG1G2
= au
kG1G2
(R0 − 1) . Therefore, if R0 > 1,
then G(x) has a root x∗ ∈ (0, x¯) such that
f(x∗, y(x∗), v(x∗))−
n(x∗)
v(x∗)
= 0,
or equivalently
n(x∗)− f(x∗, y(x∗), v(x∗))v(x∗) = 0.
We conclude that, for R0 > 1 there exists another equilibrium E1 = (x1, y1, v1, 0) with x1 =
x∗ ∈ (0, x¯), y1 = φ(x1) and v1 =
kG2φ(x1)
u
. Moreover, using the fact that R0 > R(x, y, v), for all
x, y, v > 0 , when R0 < 1 we have R(x, y, v) < 1. Using (33) we arrive to
n(x)− f(x, y, v)v > 0, ∀x, y, v > 0,
so equation (26) never holds. Therefore, E1 exists iff R0 > 1.
Next we show that E1 = (x1, y1, v1, 0) in unique. Suppose, to the contrary, there exists another
CTL-IE equilibrium E∗1 = (x
∗
1, y
∗
1, v
∗
1, 0). Without of loss generality, we assumed that x
∗
1 < x1.
Then x1 ∈ Xn implies that n(x
∗
1) > n(x1). By virtue x1 ∈ Xh, we get f(x
∗
1, y
∗
1, v
∗
1) < f(x1, y1, v1).
On other hand, it follows from (33) f(x∗1, y
∗
1, v
∗
1) = f(x1, y1, v1) = au/kG1G2. This a contradiction,
and thus E1 is the unique CTL-IE.
Note that the CTL-AE E2 = (x2, y2, v2, z2) exists if (x2, y2, v2, z2) ∈ R
4
+ satisfies the equilibrium
equations (26)-(29) and ϕ1(y) = b/cG3. The four equations of system (21) and (H2) imply that
y2 = ϕ
−1
1
(
b
cG3
)
. (34)
Note that the values xˆ, yˆ, vˆ used to define R1 clearly satisfy the equilibrium equations. Solving
the equation (27) for z and using (H2) yields zˆ = φ−12
(
kG1G2f(xˆ,yˆ,vˆ)−au
pu
)
= φ−12
(
a(R1−1))
p
)
. Using
the fact that ϕ−12 is defined on [0,∞) we conclude that the CTL-AE E2 = (xˆ, yˆ, vˆ, zˆ) exists if and
only if R1 > 1.
Now we will prove that E2 is unique. Suppose there exists another CTL-AE, E
∗
2 = (x
∗
2, y
∗
2, v
∗
2, z
∗
2).
Then y2 = y
∗
2 and v2 = v
∗
2. Without of generality, we assume that x
∗
2 < x2. Then x2 ∈ Xn
implies n(x∗2) > n(x2). Note that n(x
∗
2) = f(x
∗
2, y2, v2) and n(x2) = f(x2, y2, v2), implies that
f(x∗2, y2, v2) > f(x2, y2, v2). This contradicts that x2 ∈ Xf(y2, v2) and hence E2 is unique.
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3. Global stability
Let R0 and R1 be defined as in previous section.
Theorem 3. If R0 < 1, then infection free-Equilibrium E0 of model (21) is globally asymptotically
stable.
Proof. Define a Lyapunov functional
V1 = x− x0 +
∫ x
x0
f(x0, 0, 0)
f(s, 0, 0)
ds+
1
G1
y +
a
kG1G2
v +
p
cG1G3
z
+
1
G1
∫ ∞
0
f1(τ)e
−α1τ
∫ t
t−τ
f(x(s), y(s), v(s))v(s)dsdτ +
a
G1G2
∫ ∞
0
f2(τ)e
−α2τ
∫ t
t−τ
ϕ1(y(s))dsdτ
+
p
G1G3
∫ ∞
0
f3(τ)
∫ t
t−τ
ϕ1(y(s))ϕ2(z(s))dsdτ,
where Gi =
∫∞
0
fi(τ),i = 1, 2, 3.
Calculating the derivative of V1 along the positive solution of system (21), it follows that
V˙1 =
(
1−
f(x0, 0, 0)
f(x, 0, 0)
)
x˙+
1
G1
y˙ +
a
kG1G2
v˙ +
p
cG1G3
z˙
+ f(x, y, v)v −
1
G1
∫ ∞
0
f1(τ)e
−α1τf(x(t− τ), y(t− τ), v(t− τ))dτ
+
a
G1
ϕ1(y)−
a
G1G2
∫ ∞
0
f2(τ)e
−α2τϕ1(y(t− τ))dτ
+
p
G1
ϕ1(y)ϕ2(z)−
p
G1G3
∫ ∞
0
f3(τ)ϕ1(y(t− τ))ϕ2(z(t− τ))dτ
=
(
1−
f(x0, 0, 0)
f(x, 0, 0)
)
(n(x)− f(x, y, v)v)
+
1
G1
(∫ ∞
0
f1(τ)e
−α1τf(x(t− τ), y(t− τ), v(t− τ))v(t− τ)− aϕ1(y)− pϕ1(y)ϕ2(z)
)
+
a
kG1G2
(
k
∫ ∞
0
f2(τ)e
−α2τϕ1(y(t− τ))− uv
)
+
p
cG1G3
(
c
∫ ∞
0
f3(τ)ϕ1(y(t− τ)ϕ2(z(t− τ))− bϕ2(z)
)
+ f(x, y, v)v −
1
G1
∫ ∞
0
f1(τ)e
−α1τf(x(t− τ), y(t− τ), v(t− τ))dτ
+
a
G1
ϕ1(y)−
a
G1G2
∫ ∞
0
f2(τ)e
−α2τϕ1(y(t− τ))dτ
+
p
G1
ϕ1(y)ϕ2(z)−
p
G1G3
∫ ∞
0
f3(τ)ϕ1(y(t− τ))ϕ2(z(t− τ))dτ.
Using n(x0) = 0 and simplifying, we get
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V˙1 = (n(x)− n(x0))
(
1−
f(x0, 0, 0)
f(x, 0, 0)
)
+
au
kG1G2
v
(
f(x, y, v)
f(x, 0, 0)
f(x0, 0, 0)kG1G2
au
− 1
)
−
pb
cG1G3
ϕ2(z)
= (n(x)− n(x0))
(
1−
f(x0, 0, 0)
f(x, 0, 0)
)
+
au
kG1G2
v
(
f(x, y, v)
f(x, 0, 0)
R0 − 1
)
−
pb
cG1G3
ϕ2(z)
≤ (n(x)− n(x0))
(
1−
f(x0, 0, 0)
f(x, 0, 0)
)
+
au
kG1G2
v (R0 − 1)−
pb
cG1G3
ϕ2(z).
Using the following inequalities:
n(x)− n(x0) < 0, 1−
f(x0, 0, 0)
f(x, 0, 0)
≥ 0 for x ≥ x0,
n(x)− n(x0) > 0, 1−
f(x0, 0, 0)
f(x, 0, 0)
≤ 0 for x < x0.
We have that
(n(x)− n(x0))
(
1−
f(x0, 0, 0)
f(x, 0, 0)
)
≤ 0.
Since R0 ≤ 1, we have V˙1 ≤ 0. Therefore the disease free E1 is stable, V˙1 = 0 if and only if
x = x0, y = 0, v = 0, z = 0. So, the largest compact invariant set in {(x, y, v, z) : V˙1 = 0} is just the
singleton E1. From LaSalle invariance principle , we conclude that E1 is globally asymptotically
stable.
Theorem 4. If R0 > 1 and R1 < 1, then CTL-IE E1, of model (21) is globally asymptotically
stable.
Proof. Consider the following Lyapunov functional:
V1 = Lˆ(t)
where
Lˆ = x− x1 −
∫ x
x1
f(x1, y1, v1)
f(s, y1, v1)
ds+
1
G1
∫ y
y1
(
1−
ϕ1(y1)
ϕ1(σ)
)
dσ +
a
kG1G2
∫ v
v1
(
1−
v1
σ
)
dσ
+
p
cG1G3
z
+
f(x1, y1, v1)v1
G1
∫ ∞
0
f1(τ)e
−α1τ
∫ τ
0
H
(
f(x(t− ω), y(t− ω), v(t− ω))v(t− ω)
f(x1, y1, v1)v1
)
dωdτ
+
aϕ1(y1)
G1G2
∫ ∞
0
f2(τ)e
−α2τ
∫ τ
0
H
(
ϕ1(t− ω)
ϕ1(y1)
)
dωdτ
+
p
G1G3
∫ ∞
0
f3(τ)
∫ τ
0
ϕ1(y(t− ω))ϕ2(z(t− ω))dωdτ.
At infected equilibrium
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n(x1)− f(x1, y1, v1)v1 = 0, (35)
f(x1, y1, v1)v1 =
aϕ1(y1)
G1
, (36)
u
kG2
=
ϕ1(y1)
v1
. (37)
Calculating the derivative of Lˆ a long positive solutions of (21), we get
V˙1 =
(
1−
f(x1, y1, v1)
f(x, y1, v1)
)
x˙+
1
G1
(
1−
ϕ1(y1)
ϕ1(y)
)
y˙ +
a
kG1G2
(
1−
v1
v
)
v˙ +
p
cG1G2
z˙
+
f(x1, y1, v1)v1
G1
∫ ∞
0
f1(τ)e
−α1τ
(
H
(
f(x, y, v)v
f(x1, y1, v1)v1
)
−H
(
f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)
f(x1, y1, v1)v1
))
dτ
+
aϕ1(y1)
G1G2
∫ ∞
0
f2(τ)e
−α2τ
(
H
(
ϕ1(y)
ϕ1(y1)
)
−H
(
ϕ1(y(t− τ))
ϕ1(y1)
))
dτ
+
p
G1
ϕ1(y)ϕ2(z)−
p
G1G3
∫ ∞
0
f3(τ)ϕ1(y(t− τ))ϕ2(z(t− τ))dτ
=
(
1−
f(x1, y1, v1)
f(x, y1, v1)
)
(n(x)− f(x, y, v)v)
+
1
G1
(
1−
ϕ1(y1)
ϕ1(y)
)(∫ ∞
0
f1(τ)e
−α1τf(x(t− τ), y(t− τ), v(t− τ))v(t− τ)− aϕ1(y)− pϕ1(y)ϕ2(z)
)
+
a
kG1G2
(
1−
v1
v
)(
k
∫ ∞
0
f2(τ)e
−α2τϕ1(y − τ)− uv
)
+
p
cG1G2
(
c
∫ ∞
0
f3(τ)ϕ1(y(t− τ))ϕ2(z(t− τ))− bϕ2(z)
)
+
f(x1, y1, v1)v1
G1
∫ ∞
0
f1(τ)e
−α1τ
(
H
(
f(x, y, v)v
f(x1, y1, v1)v1
)
−H
(
f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)
f(x1, y1, v1)v1
))
dτ
+
aϕ1(y1)
G1G2
∫ ∞
0
f2(τ)e
−α2τ
(
H
(
ϕ1(y)
ϕ1(y1)
)
−H
(
ϕ1(y(t− τ))
ϕ1(y1)
))
dτ
+
p
G1
ϕ1(y)ϕ2(z)−
p
G1G3
∫ ∞
0
f3(τ)ϕ1(y(t− τ))ϕ2(z(t− τ))dτ.
Using (35)-(37), we, get
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V˙1 = (n(x)− n(x1))
(
1−
f(x1, y1, v1)
f(x, y1, v1)
)
+
aϕ1(y1)
G1
(
1−
f(x1, y1, v1)
f(x, y1, v1)
+
f(x, y, v)v
f(x, y1, v1)v1
)
+
aϕ1(y1)
G1
(
1−
1
G1
∫ ∞
0
f1(τ)e
−α1τ
ϕ1(y1)
ϕ1(y)
v(t− τ)
v1
f(x(t− τ, y(t− τ), v(t− τ)))
f(x1, y1, v1)
)
dτ
+
aϕ1(y1)
G1
[
1
G1
∫ ∞
0
f1(τ)e
−α1τ ln
(
f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)
f(x1, y1, v1)v1
)
dτ
]
+
aϕ1(y1)
G1
[
1
G2
∫ ∞
0
f2(τ)e
−α2τ ln
(
ϕ1(y(t− τ))
ϕ1(y1)
dτ
)
− ln
(
f(x, y, v)vϕ1(y)
f(x1, y1, v1)v1ϕ1(y1)
)]
+
pbϕ1(z)
cG1G3
(
cG3ϕ1(y1)
b
− 1
)
.
Therefore
V˙1 = (n(x)− n(x1))
(
1−
f(x1, y1, v1)
f(x, y1, v1)
)
+
aϕ1(y1)
G1
(
1−
v
v1
+
f(x, y1, v1)
f(x, y, v)
+
f(x, y, v)v
f(x, y1, v1)v1
)
−
aϕ1(y1)
G1
[
H
(
f(x1, y1, v1)
f(x, y1, v1)
)
+H
(
f(x, y1, v1)
f(x, y, v)
)]
−
aϕ1(y1)
G1
[
1
G1
∫ ∞
0
f1(τ)e
−α1τH
(
ϕ1(y1)
ϕ1(y)
v(t− τ)
v1
f(x(t− τ), y(t− τ), z(t− τ))
f(x1, y1, v1)
)
dτ
]
−
aϕ1(y1)
G1
[
1
G2
∫ ∞
0
f2(τ)e
−α2τH
(
ϕ1(y(t− τ))v1
ϕ1(y1)v
)
dτ
]
+
pbϕ1(z)
cG1G3
(R1 − 1) .
Using the inequalities:
n(x)− n(x1) < 0, 1−
f(x1, y1, v1)
f(x, y1, v1)
≥ 0 for x ≥ x1,
n(x)− n(x1) > 0, 1−
f(x1, y1, v1)
f(x, y1, v1)
≤ 0 for x < x1.
We have that
(
1−
x
x1
)(
1−
f(x1, y1, v1)
f(x, y1, v1)
)
≤ 0,
− 1−
v
v1
+
f(x, y1, v1)
f(x, y, v)
+
v
v1
f(x, y, v)
f(x, y1, v1)
=
(
1−
f(x, y, v)
f(x, y1, v1)
)(
f(x, y1, v1)
f(x, y, v)
−
v
v1
)
≤ 0.
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Since R1 ≤ 1, we have V˙1 ≤ 0, thus E1 is stable. V˙1 = 0 if and only if x = x1, y = y1, v =1, z = 0.
So, the largest compact invariant set in {(x, y, v, z) : v˙1 = 0} is the singleton E1. From LaSalle
invariance principle, we conclude that E1 is globally asymptotically stable.
Theorem 5. Assume that i) − H4 hold and f3(τ) = δ(τ). If R1 > 1, then the CTL-AE, E2 is
Globally asymptotically stable.
Proof. Define a Lyapunov functional for E2.
V2 = x− x2 −
∫ x
x2
f(x2, y2, v2)
f(s, y2, v2)
ds+
1
G1
∫ y
y2
(
1−
ϕ1(y2)
ϕ1(σ)
)
dσ +
a + pϕ2(z2)
kG1G2
∫ v
v2
(
1−
v2
σ
)
dσ
+
p
cG1
∫ z
z2
(
1−
ϕ2(z2)
ϕ2(σ)
)
dσ
+
1
G1
f(x2, y2, v2)v2
∫ ∞
0
f1(τ)e
−α1τ
∫ t
t−τ
H
(
f(x(s), y(s), v(s))v(s)
f(x2, y2, v2)v2
)
dsdτ
+
a+ pϕ2(z2)
kG1G2
ϕ1(y2)
∫ ∞
0
f2(τ)e
−α2τ
∫ t
t−τ
H
(
ϕ1(y(s))
ϕ1(y2)
)
dsdτ.
The derivative of V2 along with the solutions of system (21) is
V˙2 =
(
1−
f(x2, y2, v2)
f(x, y2, v2)
)
x˙+
1
G1
(
1−
ϕ1(y2)
ϕ1(y)
)
y˙ +
a+ pϕ2(z2)
kG1G2
(
1−
v2
v
)
v˙
+
p
cG1
∫ z
z2
(
1−
ϕ2(z2)
ϕ2(z)
)
z˙ +
1
G1
f(x2, y2, v2)v2
∫ ∞
0
f1(τ)e
−α1τ
[
H
(
f(x, y, v)v
f(x2, y2, v2)v2
)
−H
(
f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)
f(x2, y2, v2)v2
)]
dτ
+
a+ pϕ2(z2)
kG1G2
ϕ1(y2)
∫ ∞
0
f2(τ)e
−α2τ
[
H
(
ϕ1(y)
ϕ1(y2)
)
−H
(
ϕ1(y(t− τ))
ϕ1(y2)
)]
dτ.
Applying n(x2) = f(x2, y2, v2)v2, f(x2, y2, v2)v2 =
1
G1
(aϕ1(y1) + pϕ1(y1)ϕ2(z2)), ϕ1(y1) =
b
c
, u
kG2
=
ϕ1(y2)
v2
, we obtain
V˙2 = (n(x)− n(x1))
(
1−
f(x2, y2, v2)
f(x, y2, v2)
)
+
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
(
1−
f(x2, y2, v2)
f(x, y2, v2)
+
f(x, y, v)v
f(x, y2, v2)v2
)
+
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
(
1−
1
G1
∫ ∞
0
f1(τ)e
−α1τ
ϕ1(y2)
ϕ1(y)
v(t− τ)
v2
f(x(t− τ, y(t− τ), v(t− τ)))
f(x1, y2, v2)
)
dτ
+
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
[
1
G1
∫ ∞
0
f1(τ)e
−α1τ ln
(
f(x(t− τ), y(t− τ), v(t− τ))v(t− τ)
f(x2, y2, v2)v2
)
dτ
]
+
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
[
1
G2
∫ ∞
0
f2(τ)e
−α2τ ln
(
ϕ1(y(t− τ))
ϕ1(y2)
dτ
)
− ln
(
f(x, y, v)vϕ1(y)
f(x2, y2, v2)v2ϕ1(y2)
)]
.
Therefore
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V˙2 = (n(x)− n(x1))
(
1−
f(x2, y2, v2)
f(x, y2, v2)
)
+
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
(
1−
v
v2
+
f(x, y2, v2)
f(x, y, v)
+
f(x, y, v)v
f(x, y2, v2)v2
)
−
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
[
H
(
f(x2, y2, v2)
f(x, y2, v2)
)
+H
(
f(x, y2, v2)
f(x, y, v)
)]
−
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
[
1
G1
∫ ∞
0
f1(τ)e
−α1τH
(
ϕ1(y2)
ϕ1(y)
v(t− τ)
v2
f(x(t− τ), y(t− τ), z(t− τ))
f(x2, y2, v2)
)
dτ
]
−
aϕ1(y2) + pϕ1(y2)ϕ2(z2)
G1
[
1
G2
∫ ∞
0
f2(τ)e
−α2τH
(
ϕ1(y(t− τ))v2
ϕ1(y2)v
)
dτ
]
.
Therefore V˙2 ≤ 0, thus E2 is stable. V˙2 = 0 if and only if x = x2, y = y2, v = v2, z = z3. So, the
largest compact invariant set in {(x, y, v, z) : V˙2 = 0} is the singleton E2. From LaSalle invariance
principle, we conclude that E2 is globally asymptotically stable.
4. Numerical simulations
In this section we present some numerical simulations to illustrate the results of stability ob-
tained in our theorems of previous sections.
Example 1. Consider the functions n(x) = λ−dx+rx
(
1− x
K
)
, φ1(y) = y, φ2(z) = z, w(y, z) = yz
and f(x, y, v) = βx
αy+γx
. Let τ1, τ2 ∈ [0,∞) two fixed delays, and set f1(τ) = δ(τ − τ1), f2(τ) =
δ(τ − τ2), f3(τ) = δ(τ), where δ is the Dirac delta function defined as∫ ∞
0
δ(τ − τi)F (τ)dτ = F (τi).
Then, the model takes the form:
x˙ = λ− dx+ rx
(
1−
x
K
)
−
βxv
αy + γx
,
y˙ =
βx(t− τ1)v(t− τ1)
αy(t− τ1) + γx(t− τ1)
e−α1τ1 − ay − pyz,
v˙ = ke−α2τ2y(t− τ2)− uv,
z˙ = cyz − bz,
Fix the parameters as λ = 200, d = 0.1, r = 0.6, K = 500, p = 1, k = 0.8, α2 = 0.05, u = 3.5, c =
0.03, b = 0.75, τ1 = 5, τ2 = 10, α1 = 0.1, α = γ = 0.001. The trivial equilibrium point is given by
E0 = (666.6666, 0, 0, 0), so the basic reproduction number R0 is obtained by:
R0 =
kG1G2f(x0, 0, 0)
au
=
ke−µτ1e−α2τ2β
auγ
= 105.10841176326923474β.
R0 ≤ 1 iff β ≤ 0.009513986. We set β = 0.003 . By theorem (2) i), we have the single
equilibrium E0 = (666.6666, 0, 0, 0) which is globally asymptotically stable by theorem (3).
Using a constant history function S = (25, 50, 10, 5) for t ∈ (0, 10) and DDE 23 tool from
Matlab, we obtain the figure (1).
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Example 2. Now, set β = 0.0096, so R0 > 1. Computing R1 from its definition we have R1 =
ke−α1τ1e−α2τ2
au
f(xˆ, yˆ, vˆ), where
yˆ =
b
c
, vˆ =
yˆke−α2τ2
u
, n(xˆ)− f(xˆ, yˆ, vˆ)vˆ = 0,
therefore R1 = 0.97091 < 1 and we have then, a second equilibrium
E1 = (659.461141, 5.962025, 0.826548, 0).
Using the history function from previous example we can plot the solution with Matlab. By
theorem (4), E1 is globally asymptotically stable as we can see in figure (2).
Finally, for β = 1, we have R0 > 1 and R1 = 6.088529, so there exists an infection free
equilibrium E0 and two equilibria
E1 = (1.461792, 152.184859, 21.098236, 0),
and
E2 = (1.537198, 25, 3.465889, 4.070823).
By theorem (5) we have global stability of equilibrium E2. The solutions are showed in figure
(3).
Example 3. In order to show that our model, generalizes the previous articles, we propose the
following incidence function to show our results:
f(x, y, v) =
βx
(1 + αy)(1 + γv)
,
this function satisfies
i) f(0, y, v) = 0, ∀y, v ≥ 0.
ii) ∂f
∂x
= β
(1+αy)(1+γv)
> 0, ∀x, y, v > 0.
iii a) ∂f
∂y
= − β xα
(αy+1)2(γv+1)
≤ 0 ∀x, y, v ≥ 0.
iii b) ∂f
∂v
= − β xγ
(αy+1)(γv+1)2
≤ 0, ∀x, y, v ≥ 0.
Set the other functions and parameters as in example 1, then we obtain model:
x˙ = λ− dx+ rx
(
1−
x
K
)
−
βxv
(1 + y)(1 + v)
,
y˙ =
βx(t− τ1)v(t− τ1)
(1 + y(t− τ1))(1 + v(t− τ1))
e−α1τ1 − ay − pyz,
v˙ = ke−α2τ2y(t− τ2)− uv,
z˙ = cyz − bz,
The infection free equilibrium is E0 = (666.6666, 0, 0, 0) as in previous cases, with R0 =
70.0722745β, so R0 > 1 iff β > 0.01427097. Therefore, if we set β = 0.1 then we have R0 > 1,
R1 = 4.9234560677357286281 and there exists two more equilibria points,
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E1 = (115.436331, 183.268932, 25.407594, 0), E2 = (481.791432, 25, 3.465889, 3.138764)
with E2 globally asymptotically stable. The solutions are showed in figure (4).
5. Conclusions
In this paper we studied the global properties of a model of infinitely distributed delayed viral
infection, that considers a nonlinear CTL immune response, given by w(y, z) = φ1(y)φ2(z) and a
general incidence function of the form f(x, y, v)v, where w and f satisfy certain conditions derived
from previous works and biological meanings. Even when there exists variety of papers that include
the CTL immune response (see for example [1, 3, 4, 5, 7]) and general incidence functions of various
types (see [5, 7, 9] ), the model proposed in this article includes a family of the works studied by
several authors, and their conclusions can be seen as a particular case of our theorems. There lies
its importance and relevance.
The model presents always an infection free positive equilibrium E0 = (x¯, 0, 0, 0), and two
types of chronic infection equilibria: the CTL inactivated infection equilibrium (CTL-IE) E1 =
(x1, y1, v1, 0) and the CTL activated infection equilibrium (CTL-AE) E2 = (x2, y2, v2, z2). The
coexistence of these equilibria is determined by the basic reproduction number R0 and the viral
reproduction number R1, those were defined in section 2 and are given in terms of parameters and
the functions f(x, y, v), fi(τ), φ1(y) and φ2(z). The results show that R0 > R1 and the system
admits always a positive infection free equilibrium E0, which is the unique equilibrium when
R0 ≤ 1. If R0 > 1 then, in addition to E0 we have only the CTL-IE (when R1 ≤ 1), or the
coexistence of the CTL-IE and CTL-AE (R1 > 1).
We proved, by construction of a Lyapunov function, that whenever the equilibrium E0 is unique
(R0 ≤ 1) and R0 6= 1, E0 is globally asymptotically stable, moreover when R0 > 1 and R1 < 1 the
CTL-IE, E1 is globally asymptotically stable. In the case of CTL-AE, E2 we obtained conditions
for global stability only in the case f3(τ) = δ(τ), ie, when the equation of z˙ does not present delay.
The results indicate that in this case, the equilibrium E2 is globally asymptotically stable when
R1 > 1 and conditions i) − H4 hold. It will be of interest to find conditions that guarantee the
global stability of the E2 with a general f3(τ), this topic can be taken as a future work.
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6. Figures
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Figure 1: Global stability of infection free equilibrium for R0 < 1.
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Figure 2: Global stability of CTL-IE E1 for R0 > 1 > R1.
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Figure 3: Global stability of CTL-AE E2 for R0 > 1, R1 > 1.
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Figure 4: Global stability of CTL-AE E2 for f(x, y, v) =
βx
(1+αy)(1+γv) , with R0 > 1, R1 > 1.
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